| Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
| contig02101 |
kiaa1704 protein |
310 |
20 |
4.63E-28 |
69.40% |
2 |
F:F; C:C |
|
|
| contig02102 |
---NA--- |
276 |
0 |
|
|
0 |
|
|
|
| contig02103 |
protein disulfide isomerase family member 3 |
630 |
20 |
2.12E-104 |
80.80% |
11 |
F:phospholipase C activity; F:protein disulfide isomerase activity; P:positive regulation of apoptosis; P:protein import into nucleus; P:cell redox homeostasis; P:protein retention in ER lumen; F:cysteine-type endopeptidase activity; C:melanosome; C:endoplasmic reticulum lumen; F:protein binding; P:signal transduction |
EC:5.3.4.1; EC:3.4.22.0 |
|
| contig02104 |
protein disulfide isomerase family member 3 |
755 |
20 |
4.43E-111 |
79.80% |
12 |
F:phospholipase C activity; F:protein disulfide isomerase activity; P:positive regulation of apoptosis; P:protein import into nucleus; P:cell redox homeostasis; C:extracellular space; P:protein retention in ER lumen; F:cysteine-type endopeptidase activity; C:melanosome; C:endoplasmic reticulum lumen; F:protein binding; P:signal transduction |
EC:5.3.4.1; EC:3.4.22.0 |
|
| contig02105 |
---NA--- |
338 |
0 |
|
|
0 |
|
|
|
| contig02106 |
phosphoserine phosphatase |
625 |
20 |
1.48E-94 |
90.85% |
4 |
P:L-serine biosynthetic process; F:phosphoserine phosphatase activity; F:protein binding; F:magnesium ion binding |
EC:3.1.3.3 |
|
| contig02107 |
flap structure-specific endonuclease 1 |
358 |
20 |
4.22E-37 |
91.65% |
8 |
P:base-excision repair; P:DNA replication; F:manganese ion binding; F:DNA binding; P:retina development in camera-type eye; C:nucleus; F:5'-flap endonuclease activity; F:5'-3' exonuclease activity |
|
|
| contig02108 |
---NA--- |
338 |
0 |
|
|
0 |
|
|
|
| contig02109 |
---NA--- |
926 |
0 |
|
|
0 |
|
|
|
| contig02110 |
---NA--- |
238 |
0 |
|
|
0 |
|
|
|
| contig02111 |
upf0197 protein c11orf10 homolog |
477 |
20 |
5.49E-29 |
96.70% |
2 |
F:F; P:P |
|
|
| contig02112 |
cytochrome p450 reductase |
320 |
20 |
1.98E-50 |
88.65% |
7 |
C:soluble fraction; C:endoplasmic reticulum membrane; C:microsome; F:NADPH-hemoprotein reductase activity; F:iron ion binding; F:FMN binding; P:electron transport |
EC:1.6.2.4 |
|
| contig02113 |
---NA--- |
244 |
0 |
|
|
0 |
|
|
|
| contig02114 |
thioredoxin reductase 3 |
250 |
20 |
9.78E-27 |
83.45% |
10 |
; P:cell proliferation; F:thioredoxin-disulfide reductase activity; F:NADP or NADPH binding; F:selenium binding; P:cell redox homeostasis; P:electron transport; F:FAD binding; C:cytosol; F:protein disulfide oxidoreductase activity |
EC:1.6.4.0; EC:1.8.1.9 |
|
| contig02115 |
calpain 2 |
289 |
20 |
2.69E-39 |
88.95% |
6 |
C:cytoplasm; P:myoblast fusion; C:plasma membrane; F:calcium-dependent cysteine-type endopeptidase activity; F:calcium ion binding; P:proteolysis |
|
|
| contig02116 |
unnamed protein product [Tetraodon nigroviridis] |
481 |
1 |
6.51E-06 |
90.00% |
0 |
|
|
|
| contig02117 |
cytochrome b5 reductase 3 |
1276 |
20 |
2.21E-96 |
88.85% |
11 |
F:cytochrome-b5 reductase activity; C:mitochondrial outer membrane; P:unsaturated fatty acid biosynthetic process; P:fatty acid elongation; F:FAD binding; P:blood circulation; C:endoplasmic reticulum membrane; P:cholesterol biosynthetic process; P:drug metabolic process; C:hemoglobin complex; P:electron transport |
EC:1.6.2.2 |
|
| contig02118 |
---NA--- |
314 |
0 |
|
|
0 |
|
|
|
| contig02119 |
transmembrane and coiled-coil domains 7 |
363 |
3 |
1.71E-14 |
66.33% |
0 |
|
|
|
| contig02120 |
---NA--- |
234 |
0 |
|
|
0 |
|
|
|
| contig02121 |
rrna-processing protein fcf1 homolog |
950 |
20 |
3.21E-97 |
95.80% |
2 |
P:rRNA processing; C:nucleus |
|
|
| contig02122 |
tuftelin interacting protein 11 |
368 |
20 |
1.34E-43 |
87.90% |
2 |
F:nucleic acid binding; C:intracellular |
|
|
| contig02123 |
---NA--- |
269 |
0 |
|
|
0 |
|
|
|
| contig02124 |
u2-associated sr140 protein |
687 |
20 |
3.63E-74 |
81.50% |
3 |
P:RNA processing; F:nucleotide binding; F:RNA binding |
|
|
| contig02125 |
---NA--- |
555 |
0 |
|
|
0 |
|
|
|
| contig02126 |
---NA--- |
283 |
0 |
|
|
0 |
|
|
|
| contig02127 |
---NA--- |
552 |
0 |
|
|
0 |
|
|
|
| contig02128 |
---NA--- |
261 |
0 |
|
|
0 |
|
|
|
| contig02129 |
angiogenic factor with g patch and fha domains 1 |
249 |
20 |
9.34E-21 |
71.20% |
6 |
P:positive regulation of angiogenesis; F:protein binding; P:cell adhesion; F:eukaryotic cell surface binding; C:extracellular region; C:perinuclear region of cytoplasm |
|
|
| contig02130 |
a-kinase anchor protein |
752 |
2 |
2.17E-17 |
54.00% |
3 |
F:nucleic acid binding; F:RNA binding; F:kinase activity |
|
|
| contig02131 |
---NA--- |
433 |
0 |
|
|
0 |
|
|
|
| contig02132 |
component of oligomeric golgi complex 4 |
330 |
20 |
1.36E-35 |
89.85% |
4 |
P:protein transport; C:Golgi membrane; C:Golgi transport complex; F:protein binding |
|
|
| contig02133 |
---NA--- |
708 |
0 |
|
|
0 |
|
|
|
| contig02134 |
---NA--- |
543 |
0 |
|
|
0 |
|
|
|
| contig02135 |
gamma-glutamyl carboxylase |
240 |
20 |
5.92E-15 |
76.60% |
2 |
F:gamma-glutamyl carboxylase activity; P:peptidyl-glutamic acid carboxylation |
|
|
| contig02136 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
| contig02137 |
lon peptidase mitochondrial |
485 |
20 |
1.45E-58 |
84.70% |
7 |
C:extracellular space; F:DNA binding; P:ATP-dependent proteolysis; F:ATP binding; F:nucleoside-triphosphatase activity; F:ATP-dependent peptidase activity; C:mitochondrion |
EC:3.6.1.15 |
|
| contig02138 |
death-associated protein 3 |
236 |
20 |
3.25E-37 |
84.30% |
5 |
P:regulation of apoptosis; P:apoptotic mitochondrial changes; C:mitochondrial ribosome; C:small ribosomal subunit; P:response to hypoxia |
|
|
| contig02139 |
---NA--- |
293 |
0 |
|
|
0 |
|
|
|
| contig02140 |
---NA--- |
250 |
0 |
|
|
0 |
|
|
|
| contig02141 |
g2 m-phase specific e3 ubiquitin ligase |
484 |
20 |
4.72E-52 |
49.55% |
10 |
F:ligase activity; C:nucleus; C:cytoplasm; F:zinc ion binding; P:protein modification process; P:ubiquitin cycle; F:protein binding; C:intracellular; F:ubiquitin-protein ligase activity; F:metal ion binding |
|
|
| contig02142 |
---NA--- |
522 |
0 |
|
|
0 |
|
|
|
| contig02143 |
---NA--- |
760 |
0 |
|
|
0 |
|
|
|
| contig02144 |
translocase of inner mitochondrial membrane 10 homolog |
1327 |
20 |
5.78E-43 |
93.20% |
9 |
F:zinc ion binding; P:zinc ion transport; F:P-P-bond-hydrolysis-driven protein transmembrane transporter activity; C:mitochondrial inner membrane presequence translocase complex; P:protein import into mitochondrial inner membrane; C:mitochondrial intermembrane space protein transporter complex; C:membrane attack complex; P:intracellular protein transmembrane transport; P:sensory perception of sound |
|
|
| contig02145 |
---NA--- |
463 |
0 |
|
|
0 |
|
|
|
| contig02146 |
electron-transferring-flavoprotein dehydrogenase |
404 |
20 |
1.16E-34 |
93.50% |
10 |
F:electron-transferring-flavoprotein dehydrogenase activity; C:membrane fraction; C:mitochondrial inner membrane; C:mitochondrial electron transfer flavoprotein complex; F:iron ion binding; P:electron transport; P:transport; F:4 iron, 4 sulfur cluster binding; C:integral to membrane; |
EC:1.5.5.1 |
|
| contig02147 |
clathrin heavy chain 1 |
224 |
20 |
2.45E-16 |
95.00% |
10 |
P:vesicle-mediated transport; F:protein transporter activity; C:clathrin coat of coated pit; C:mitochondrion; C:clathrin coat of trans-Golgi network vesicle; P:protein complex assembly; C:melanosome; F:protein binding; P:intracellular protein transport; F:structural molecule activity |
|
|
| contig02148 |
---NA--- |
332 |
0 |
|
|
0 |
|
|
|
| contig02149 |
cortactin-binding protein 2 |
1584 |
1 |
3.55E-05 |
39.00% |
0 |
|
|
|
| contig02150 |
thioredoxin domain containing 5 |
502 |
20 |
2.97E-20 |
68.05% |
3 |
C:endoplasmic reticulum lumen; P:anti-apoptosis; F:isomerase activity |
|
|
| contig02151 |
---NA--- |
301 |
0 |
|
|
0 |
|
|
|
| contig02152 |
---NA--- |
135 |
0 |
|
|
0 |
|
|
|
| contig02153 |
---NA--- |
268 |
0 |
|
|
0 |
|
|
|
| contig02154 |
postreplication repair protein hrad18p |
525 |
20 |
6.23E-75 |
76.40% |
6 |
C:chromatin; F:protein binding; F:damaged DNA binding; C:nucleus; F:zinc ion binding; P:DNA repair |
|
|
| contig02155 |
x-ray repair complementing defective repair in chinese hamster cells 5 |
476 |
20 |
3.80E-54 |
72.20% |
9 |
F:double-stranded DNA binding; P:DNA recombination; P:response to ionizing radiation; F:ATP-dependent DNA helicase activity; P:DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis; P:double-strand break repair via nonhomologous end joining; F:protein binding; P:negative regulation of apoptosis; C:nucleus |
|
|
| contig02156 |
---NA--- |
258 |
0 |
|
|
0 |
|
|
|
| contig02157 |
---NA--- |
203 |
0 |
|
|
0 |
|
|
|
| contig02158 |
retinoblastoma binding protein 2 |
251 |
20 |
1.59E-36 |
88.40% |
12 |
P:chromatin modification; F:zinc ion binding; P:regulation of transcription, DNA-dependent; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:transcription activator activity; F:protein binding; F:transcription factor activity; C:cyclin-dependent protein kinase activating kinase holoenzyme complex; P:multicellular organismal development; F:iron ion binding; P:transcription from RNA polymerase II promoter; P:positive regulation of transcription |
EC:1.13.11.0 |
|
| contig02159 |
luc7-like 2 |
456 |
20 |
1.18E-31 |
98.30% |
4 |
F:protein binding; P:negative regulation of striated muscle tissue development; C:nucleus; F:zinc ion binding |
|
|
| contig02160 |
prp18 pre-mrna processing factor 18 homolog |
931 |
20 |
1.68E-58 |
98.20% |
3 |
P:mRNA processing; C:spliceosomal complex; P:RNA splicing |
|
|
| contig02161 |
ankyrin repeat and zinc finger domain containing 1 |
425 |
20 |
8.06E-28 |
74.20% |
1 |
F:metal ion binding |
|
|
| contig02162 |
chromosome 7 open reading frame 36 |
410 |
20 |
3.45E-39 |
66.35% |
2 |
F:F; P:P |
|
|
| contig02163 |
---NA--- |
522 |
0 |
|
|
0 |
|
|
|
| contig02164 |
mediator of cell motility 1 |
351 |
20 |
1.47E-21 |
94.80% |
2 |
C:nucleus; C:cytoplasm |
|
|
| contig02165 |
---NA--- |
619 |
0 |
|
|
0 |
|
|
|
| contig02166 |
---NA--- |
344 |
0 |
|
|
0 |
|
|
|
| contig02167 |
unnamed protein product [Tetraodon nigroviridis] |
284 |
1 |
4.49E-07 |
82.00% |
0 |
|
|
|
| contig02168 |
---NA--- |
241 |
0 |
|
|
0 |
|
|
|
| contig02169 |
---NA--- |
134 |
0 |
|
|
0 |
|
|
|
| contig02170 |
---NA--- |
99 |
0 |
|
|
0 |
|
|
|
| contig02171 |
---NA--- |
381 |
0 |
|
|
0 |
|
|
|
| contig02172 |
---NA--- |
117 |
0 |
|
|
0 |
|
|
|
| contig02173 |
threonyl-trna synthetase-like 2 |
843 |
20 |
2.34E-61 |
85.05% |
4 |
C:cytoplasm; F:threonine-tRNA ligase activity; F:ATP binding; P:threonyl-tRNA aminoacylation |
EC:6.1.1.3 |
|
| contig02174 |
glutamic acid and leucine rich protein 1 |
132 |
20 |
1.32E-06 |
80.80% |
3 |
C:cytoplasm; P:transcription; C:nucleus |
|
|
| contig02175 |
---NA--- |
270 |
0 |
|
|
0 |
|
|
|
| contig02176 |
---NA--- |
314 |
0 |
|
|
0 |
|
|
|
| contig02177 |
---NA--- |
554 |
0 |
|
|
0 |
|
|
|
| contig02178 |
---NA--- |
275 |
0 |
|
|
0 |
|
|
|
| contig02179 |
c11orf46 homolog |
169 |
20 |
6.14E-12 |
84.75% |
2 |
P:P; C:C |
|
|
| contig02180 |
---NA--- |
515 |
0 |
|
|
0 |
|
|
|
| contig02181 |
mgc83791 protein |
943 |
20 |
1.07E-60 |
57.60% |
0 |
|
|
|
| contig02182 |
---NA--- |
238 |
0 |
|
|
0 |
|
|
|
| contig02183 |
---NA--- |
275 |
0 |
|
|
0 |
|
|
|
| contig02184 |
lysophosphatidic acid receptor 1 |
759 |
20 |
8.96E-43 |
74.05% |
5 |
P:activation of phospholipase C activity; C:integral to plasma membrane; F:rhodopsin-like receptor activity; P:positive regulation of I-kappaB kinase/NF-kappaB cascade; P:elevation of cytosolic calcium ion concentration |
|
|
| contig02185 |
---NA--- |
348 |
0 |
|
|
0 |
|
|
|
| contig02186 |
---NA--- |
353 |
0 |
|
|
0 |
|
|
|
| contig02187 |
cysteine-rich with egf-like domains 2 |
1126 |
20 |
3.51E-128 |
74.85% |
7 |
F:calcium channel activity; P:calcium ion transport; F:calcium ion binding; C:signal recognition particle, endoplasmic reticulum targeting; C:extracellular region; P:negative regulation of signal transduction; F:calcium channel inhibitor activity |
EC:3.6.5.4 |
|
| contig02188 |
cold shock domain containing rna-binding |
282 |
20 |
4.74E-26 |
78.55% |
2 |
F:DNA binding; P:regulation of transcription, DNA-dependent |
|
|
| contig02189 |
leucine rich repeat containing 40 |
253 |
3 |
6.08E-07 |
72.33% |
2 |
P:P; C:C |
|
|
| contig02190 |
thioredoxin family trp26 |
329 |
20 |
8.93E-49 |
78.20% |
3 |
F:F; P:P; C:C |
|
|
| contig02191 |
---NA--- |
250 |
0 |
|
|
0 |
|
|
|
| contig02192 |
pyruvate kinase |
775 |
20 |
1.28E-116 |
90.75% |
4 |
F:pyruvate kinase activity; F:potassium ion binding; F:magnesium ion binding; P:glycolysis |
EC:2.7.1.40 |
|
| contig02193 |
---NA--- |
491 |
0 |
|
|
0 |
|
|
|
| contig02194 |
cytoplasmic linker associated protein 2 |
241 |
20 |
4.66E-36 |
95.40% |
10 |
P:negative regulation of microtubule depolymerization; P:establishment or maintenance of cell polarity; F:microtubule plus-end binding; C:centrosome; P:cell division; C:cytoplasmic microtubule; P:mitosis; C:kinetochore microtubule; F:galactoside 2-alpha-L-fucosyltransferase activity; C:Golgi apparatus |
EC:2.4.1.69 |
|
| contig02195 |
proteasome ( macropain) 26s 5 |
849 |
20 |
1.90E-135 |
97.25% |
12 |
P:proteasomal ubiquitin-dependent protein catabolic process; C:cytosol; F:transcription cofactor activity; C:proteasome complex; F:thyrotropin-releasing hormone receptor binding; F:ATP binding; F:ATPase activity; P:negative regulation of programmed cell death; P:positive regulation of gene-specific transcription; C:holo TFIIH complex; P:negative regulation of transcription; P:transcription from RNA polymerase II promoter |
|
|
| contig02196 |
motile sperm domain containing 2 |
608 |
20 |
2.16E-71 |
75.40% |
1 |
C:membrane |
|
|
| contig02197 |
retinol dehydrogenase 11 (all-trans 9-cis 11-cis) |
268 |
20 |
1.97E-26 |
85.35% |
5 |
C:endoplasmic reticulum membrane; F:binding; P:retinol metabolic process; F:retinol dehydrogenase activity; C:integral to membrane |
EC:1.1.1.105 |
|
| contig02198 |
cdk5 regulatory subunit associated protein 3 |
279 |
20 |
1.83E-16 |
86.80% |
5 |
P:cell proliferation; F:neuronal Cdc2-like kinase binding; P:regulation of neuron differentiation; P:brain development; P:regulation of cyclin-dependent protein kinase activity |
|
|
| contig02199 |
checkpoint protein hus1 |
533 |
1 |
3.18E-05 |
93.00% |
0 |
|
|
|
| contig02200 |
malate cytoplasmic |
842 |
20 |
1.94E-116 |
91.90% |
7 |
C:cytoplasm; F:binding; F:L-malate dehydrogenase activity; P:malate metabolic process; P:tricarboxylic acid cycle intermediate metabolic process; P:tricarboxylic acid cycle; P:glycolysis |
EC:1.1.1.37 |
|
100 Rows returned.
Helpdesk 